Showing posts with label T-Cell. Show all posts
Showing posts with label T-Cell. Show all posts

Tuesday, June 9, 2015

Attend IBC's Immuno-Oncology Conference in Alexandria, VA for FREE as a Guest Blogger


Earn a complimentary all-access pass to Immuno-Oncology conference by serving as a Guest Blogger at the event. As a Guest Blogger, you’ll have access to the Immuno-Oncology event’s comprehensive agenda attracting the best insights from around the world, right in Alexandria, VA in September.





Immuno-Oncology Conference
September 30-October 1, 2015
Hilton Alexandria Mark Center, Alexandria, VA


We are looking for an industry expert to be the face of the IBC's Immuno-Oncology social media campaign. The premise is to provide immuno-oncology and cancer immunotherapies - related articles, whitepapers, and overall original content.
Some of the topics of the conference are: 
  • cancer vaccines;
  • T-cell therapy;
  • agnostic antibodies;
  • combination therapies and others.

What You get:
  • FREE pass to IBC's Immuno-Oncology conference (valued up to $1,999);
  • Extensive social learning activities;
  • Exclusive access to a networking community in the industry of your interest!
You also have a chance to GAIN exposure through our five health related-blogs with over 2000 unique visitors monthly each and more than 20 healthcare LinkedIn groups.

Learn more about the IBC's Immuno-Oncology conference event by visiting the website:

Interested and want to learn more about this opportunity please contact Amanda Caterina at acaterina@iirusa.com or directly at 646-895-7339.

We hope to have you join us in Alexandria!

Cheers,
The IBC's Immuno-Oncology Team

@ibcusa
#Immuno15
Future of Biopharma Blog http://futurebiopharma.blogspot.com/


Share this article with your social network, just click below to share now!


Thursday, May 28, 2015

Create Your Own Pathway for an Answer to Cancer

As innovations and discoveries in cancer immunotherapies progress at lightning speed, it is critical to understand the successes and challenges with current immunotherapies to separate the hype from the real opportunities.

IBC's Immuno-Oncology event develops tactics for improving the efficacy and response rates with first generation immunotherapies and builds a strategy for utilizing combination therapies, t-cell therapies, and checkpoint inhibitors to propel the next wave of cancer immunotherapies.

Immuno-Oncology
Advancing the Next Generation of Cancer Immunotherapies
September 31-October 1, 2015
Hilton Alexandria Marks Center
Alexandria, Virginia

Download the Immuno-Oncology brochure now to create your pathway for an answer to cancer: http://bit.ly/1KB4Nkg

Register today and explore the latest advances in Immuno-Oncology to:
  • Develop next generation immunotherapies by understanding recent advances made with CAR-T and T-Cell therapies, checkpoint inhibitors, cancer vaccines, and agnostic antibodies
  • Create a successful combination therapy strategy by gaining insights from global leaders on effective combinations
Optimize the discovery and development of your promising immunotherapies by hearing best practices and lessons learned from the first wave of cancer immunotherapies.

We hope to see you this fall!

Register by June 19th and save up to $400: http://bit.ly/1KB4Nkg

Best,
The Immuno-Oncology Team
@ibcusa

Futurebiopharma.blogspot.com


Share this article with your social network, just click below to share now!